摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,2R,19R,22R,34S,37R,40R,52S)-5,15-dichloro-2,26,31,44,47,49,64-heptahydroxy-22-[(2-methylpropan-2-yl)oxycarbonylamino]-21,35,38,54,56,59-hexaoxo-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid | 104581-77-3

中文名称
——
中文别名
——
英文名称
(1S,2R,19R,22R,34S,37R,40R,52S)-5,15-dichloro-2,26,31,44,47,49,64-heptahydroxy-22-[(2-methylpropan-2-yl)oxycarbonylamino]-21,35,38,54,56,59-hexaoxo-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid
英文别名
——
(1S,2R,19R,22R,34S,37R,40R,52S)-5,15-dichloro-2,26,31,44,47,49,64-heptahydroxy-22-[(2-methylpropan-2-yl)oxycarbonylamino]-21,35,38,54,56,59-hexaoxo-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid化学式
CAS
104581-77-3
化学式
C63H53Cl2N7O20
mdl
——
分子量
1299.05
InChiKey
PLVIBWSHKFMVSL-YYMLIVBDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    92
  • 可旋转键数:
    4
  • 环数:
    13.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    420
  • 氢给体数:
    15
  • 氢受体数:
    20

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationships
    作者:Adriano Malabarba、Aldo Trani、Paolo Strazzolini、Giuseppe Cietto、Pietro Ferrari、Giorgio Tarzia、Rosa Pallanza、Marisa Berti
    DOI:10.1021/jm00131a007
    日期:1989.11
    function of teicoplanin A2 (CTA) and its acidic hydrolysis pseudoaglycons (TB, TC) and aglycon (TD) with amines carrying various functional groups and chains produced amide derivatives with different isoelectric points and lipophilicities. Amide formation did not affect the ability of these compounds to bind to Ac2-L-Lys-D-Ala-D-Ala, a model for the natural peptide binding site in bacterial cell walls
    替考拉宁A2(CTA)的羧基官能团及其酸性水解假糖胺(TB,TC)和糖苷配基(TD)与带有各种官能团和链的胺的缩合产生具有不同等电点和亲脂性的酰胺衍生物。酰胺的形成并不影响这些化合物与Ac2-L-Lys-D-Ala-D-Ala结合的能力,Ac2-L-Lys-D-Ala-D-Ala是细菌细胞壁中天然肽结合位点的模型。发现替考拉宁酰胺的抗微生物活性主要取决于它们的离子和亲脂特性以及所存在的糖的类型和数量。带正电荷的酰胺通常比未修饰的针对革兰氏阳性生物的抗生素具有更高的体外活性。特别是,CTA的大多数碱性酰胺对凝结酶阴性葡萄球菌的活性均明显高于替考拉宁。少量的TC酰胺和大多数的TD酰胺对革兰氏阴性菌也显示出一定的活性。在小鼠实验性化脓性链球菌败血症中,皮下给药时,某些碱性酰胺比母体替考拉宁更具活性。通过口服途径,一些CTA也比替考拉宁更有效。
  • MALABARBA, ADRIANO;FERRARI, PIETRO;CIETTO, GIUSEPPE;PALLANZA, ROSA;BERTI,+, J. ANTIBIOTICS, 42,(1989) N2, C. 1800-1816
    作者:MALABARBA, ADRIANO、FERRARI, PIETRO、CIETTO, GIUSEPPE、PALLANZA, ROSA、BERTI,+
    DOI:——
    日期:——
  • Structural Modifications of the Active Site in Teicoplanin and Related Glycopeptides. 1. Reductive Hydrolysis of the 1,2- and 2,3-Peptide Bonds
    作者:Adriano Malabarba、Romeo Ciabatti、Jürgen Kettenring、Pietro Ferrari、Károly Vékey、Elvio Bellasio、Maurizio Denaro
    DOI:10.1021/jo941809v
    日期:1996.1.1
    Reaction of teicoplanin glycopeptides with sodium borohydride in aqueous ethanol solutions produced open pentapeptide derivatives in which the amide bond between amino acids 2 and 3 was hydrolyzed and the carboxyl group of amino acid 2 was reduced to a primary alcohol. Other glycopeptides of the dalbaheptide family, such as vancomycin, ristocetin, and A-40,926, underwent selective reductive hydrolysis (RH) of the heptapeptide backbone at the same position as in teicoplanins, while antibiotic A-42,867 and vancomycin hexapeptide were resistant. Also, teicoplanin and vancomycin were resistant to RH-treatment when the N-terminus was protected as carbamate. In contrast, open hexapeptides in which the 1,2-peptide bond was hydrolyzed and the carboxyl group of amino acid 1 was reduced to hydroxymethyl were obtained from carbamate derivatives of sugar-free compounds deglucoteicoplanin (TD) and vancomycin-aglycon (VA) under RH-conditions. Limited to BOC or CBZ-TD, the 3,4-amide bond was also affected. A possible RH-mechanism is proposed for natural glycopeptides and their derivatives. Teicoplanin-derived RH penta- and hexapeptides maintained residual antibacterial activity. As other analogous RH-glycopeptides, they are key intermediates for the synthesis of new members of this family of antibiotics. A synthetic approach to ring-closed derivatives of TD hexapeptide alcohol (TDHPA) and their activities are also reported.
  • Thermal Atropisomerism of Teicoplanin Aglycon Derivatives:  Preparation of the <i>P</i>,<i>P</i>,<i>P</i> and <i>M</i>,<i>P</i>,<i>P</i> Atropisomers of the Teicoplanin Aglycon via Selective Equilibration of the DE Ring System
    作者:Dale L. Boger、Jian-Hui Weng、Susumu Miyazaki、J. Jeffrey McAtee、Steven L. Castle、Seong Heon Kim、Yoshiki Mori、Olivier Rogel、Harald Strittmatter、Qing Jin
    DOI:10.1021/ja002376i
    日期:2000.10.1
    a series of key aglycon derivatives, including those containing a cleaved FG ring system, and a study of their thermal atropisomerism are detailed. In all cases, selective equilibration of the DE ring system was observed to provide a 1:1 mixture of P:M atropisomers under conditions in which the AB and CD atropisomer stereochemistry were unaffected. The DE atropisomer equilibration was found to occur
    详细介绍了替考拉宁降解为一系列关键苷元衍生物,包括那些含有裂解 FG 环系统的衍生物,并对其热阻转异构现象进行了研究。在所有情况下,在 AB 和 CD 阻转异构体立体化学不受影响的条件下,观察到 DE 环系统的选择性平衡以提供 P:M 阻转异构体的 1:1 混合物。发现 DE 阻转异构体平衡发生时,6a(完整 FG 环系统)和 10/12(裂解 FG 环系统)的 Ea 分别为 29.3 和 24.8-25.2 kcal/mol,与万古霉素苷元相当DE 环系统 (Ea = 23.6 kcal/mol) 并且比 CD (Ea = 30.4 kcal/mol) 或 O-甲基化 AB 环系统 (Ea = 37.8 kcal/mol) 更容易。符合直觉预期,完整的替考拉宁 FG 环系统减慢了异构化的速度,贡献了大约。Ea 为 4.0 kcal/mol(6a 对 10),替考拉宁无环 FG 衍生物上庞大的
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物